{\rtf1\ansi\ansicpg1252\cocoartf1348\cocoasubrtf170
{\fonttbl\f0\fnil\fcharset0 Calibri;}
{\colortbl;\red255\green255\blue255;}
\paperw11900\paperh16840\margl1440\margr1440\vieww10800\viewh8400\viewkind0
\pard\tx560\tx1120\tx1680\tx2240\tx2800\tx3360\tx3920\tx4480\tx5040\tx5600\tx6160\tx6720\pardirnatural

\f0\fs22\fsmilli11040 \cf0 FaeA1 was purified by size exclusion chromatography using an \'c4KTApurifier 10 analytical system (GE Healthcare, Uppsala, Sweden) equipped with a Superdex\'99 75 analytical column (10/300 GL, 1 column volume (CV) = 23.56 ml; GE Healthcare) at a flow rate of 0.5 ml/min at 20 \'b0C. The sample was manually injected via a 200 \uc0\u956 l sample loop and eluted with 50 mM NaCl in 50 mM sodium acetate buffer (pH 5.0). Fractions of 200 \u956 l were collected in microtiter plates using an \'c4KTA Frac-950 fraction collector (GE Healthcare).}